Clinical trial
Oltipraz in the Prevention of Lung Cancer in People Who Smoke
NCT00006457 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00006457 |
|---|---|
| Title | Oltipraz in the Prevention of Lung Cancer in People Who Smoke |
| Official title | Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | oltipraz |
| Start date | Aug 1, 2000 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | May 30, 2003 |
| Last update posted | Jun 11, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: